→
Align Technology Inc (ALGN) currently trades at $157.25, down 2.04% from a previous close of $160.53. With a market cap of $11.26B and a P/E ratio of 26.35, the stock's valuation is moderate compared to its EPS growth of 8.83% and revenue growth of 2.89%. While the company beat earnings estimates in three of the last four quarters, the stock's recent performance and the mixed analyst sentiment warrant a neutral stance.
Investors should hold their positions in ALGN until clearer growth signals emerge from upcoming quarters.
Align Technology's strong earnings performance, with a Q1 2026 EPS of $2.58 beating the estimate of $2.33, indicates solid operational execution. Additionally, the company's P/S ratio of 2.77 remains attractive in the health care sector, suggesting potential for share price appreciation as revenues grow.
Despite the earnings beats, Align's revenue growth of only 2.89% year-over-year raises concerns about its ability to expand in a competitive market. Furthermore, the stock is trading significantly below its 52-week high of $208.30, suggesting potential weakness in investor sentiment.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates ALGN as Neutral. Investors should hold their positions in ALGN until clearer growth signals emerge from upcoming quarters.
Despite the earnings beats, Align's revenue growth of only 2.89% year-over-year raises concerns about its ability to expand in a competitive market. Furthermore, the stock is trading significantly below its 52-week high of $208.30, suggesting potential weakness in investor sentiment.
Align Technology's strong earnings performance, with a Q1 2026 EPS of $2.58 beating the estimate of $2.33, indicates solid operational execution. Additionally, the company's P/S ratio of 2.77 remains attractive in the health care sector, suggesting potential for share price appreciation as revenues grow.
Align Technology Inc (ALGN) currently trades at $157.25, down 2.04% from a previous close of $160.53. With a market cap of $11.26B and a P/E ratio of 26.35, the stock's valuation is moderate compared to its EPS growth of 8.83% and revenue growth of 2.89%. While the company beat earnings estimates in three of the last four quarters, the stock's recent performance and the mixed analyst sentiment warrant a neutral stance.
Align Technology Inc (ALGN) currently trades at $157.25, down 2.04% from a previous close of $160.53. With a market cap of $11.26B and a P/E ratio of 26.35, the stock's valuation is moderate compared to its EPS growth of 8.83% and revenue growth of 2.89%. While the company beat earnings estimates in three of the last four quarters, the stock's recent performance and the mixed analyst sentiment warrant a neutral stance. Our overall verdict is Neutral.
Helm Terminal offers free AI-powered stock analysis for ALGN at helmterminal.dev/analyze/ALGN, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.